Bionsight
Chuncheon
About Bionsight
Bionsight is a drug discovery company that uses Chemoproteomics interweaved with AI to speed up the drug development process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: bionsight.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Machine Learning, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bionsight-84062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.